Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Myeloid 2

Conditions

Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma 3Leukemia 3Hematologic Neoplasms 3Graft vs Host Disease 3Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Mast-Cell 1Leukemia, Lymphoid 1GATA2 Deficiency 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 5fludarabine 4Mycophenolic Acid 4fludarabine phosphate 3blinatumomab 3Whole-Body Irradiation 3Tacrolimus 3Busulfan 3asciminib 2Rituximab 2Inotuzumab Ozogamicin 2Cytarabine 2Cyclosporine 2venetoclax 1tocilizumab 1ruxolitinib 1ricolinostat 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1nilotinib 1idelalisib 1ibrutinib 1ceralasertib 1Vincristine 1Thiotepa 1Surveys and Questionnaires 1Prednisone 1Midazolam 1Methotrexate 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Leukemia × Tacrolimus × 30 days × Clear all
NCT01135329 2026-05-27

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
15 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07524530 2026-05-27

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07566377 2026-05-14

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
71 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡